(Q36972692)

17 August 2017

1 reference

title

Menopausal transition and depression: who is at risk and how to treat it? (English)

1 reference

17 August 2017

Claudio N Soares

1

1 reference

17 August 2017

language of work or name

1 reference

1 October 2007

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

17 August 2017

published in

1 reference

17 August 2017

volume

7

1 reference

17 August 2017

issue

10

1 reference

17 August 2017

page(s)

1285-1293

1 reference

Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Estrogen-serotonin interactions: implications for affective regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Adolescent onset of the gender difference in lifetime rates of major depression: a theoretical model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Psychologic distress during menopause: associations across the reproductive life cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Effects of gonadal steroids in women with a history of postpartum depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Characteristics of women with premenstrual dysphoric disorder (PMDD) who did or did not report history of depression: a preliminary report from the Harvard Study of Moods and Cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Hormones and menopausal status as predictors of depression in women in transition to menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Role of female gonadal hormones in the CNS: clinical and experimental aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Effects of sex steroid hormones on the neuroendocrine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Estrogen and the aging brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Sleep disruption and mood changes associated with menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

The Manitoba Project: a re-examination of the link between menopause and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Patterns of depressed mood across the menopausal transition: approaches to studying patterns in longitudinal data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Associations of hormones and menopausal status with depressed mood in women with no history of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Risk for New Onset of Depression During the Menopausal Transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Special considerations in treating bipolar disorder in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

The perimenopause and affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Androgen therapy in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Correlates of circulating androgens in mid-life women: the study of women's health across the nation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Sex steroids and affect in the surgical menopause: a double-blind, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Transdermal testosterone treatment in women with impaired sexual function after oophorectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Empty nest or revolving door? A prospective study of women's quality of life in midlife during the phase of children leaving and re-entering the home.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Pathways to depressed mood for midlife women: observations from the Seattle Midlife Women's Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Approach to menopausal symptoms in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Medial frontal cortex perfusion abnormalities as evaluated by positron emission tomography in women with climacteric symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Insomnia in women: an overlooked epidemic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Assessment and treatment of hot flushes and menopausal mood disturbance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

An open trial of mirtazapine in menopausal women with depression unresponsive to estrogen replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1285

10.1586/14737175.7.10.1285

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference